# Vanderbilt Health: six blood proteins in 8-year-olds match a cardiometabolic risk signature in adults

- Published: 2026-11-04 23:49 UTC
- Section: Life & Health › Medicine
- Tags: cardiometabolic risk in children, circulating proteins, blood test at age 8, Vanderbilt Health study, Nature Metabolism 2026, UK Biobank cohort, GLP-1 analogues, protein signature
- URL: https://realtech.media/news/rt-a73799e634d1bb3bfc624834_vanderbilt_health_six/

**In blood samples from 273 children, six of more than 5,000 circulating proteins were linked to cardiometabolic risk; none of the children was followed into adulthood.**

![Vanderbilt Health: six blood proteins in 8-year-olds match a cardiometabolic risk signature in adults](https://sgzwpqqelzmajkcubgkl.supabase.co/storage/v1/object/public/rt-media/2026/11/02f61f3d0bc6f740.avif)
*Futura Sciences*

Researchers from Vanderbilt Health, UTHealth Houston and the University of North Carolina at Chapel Hill identified six circulating proteins associated with cardiometabolic risk in children's blood. The work was published in Nature Metabolism on 11 September 2026, according to Futura Sciences. It started from blood samples of 273 children, more than a third of whom already had physical features linked to cardiovascular, kidney and metabolic disease [1].

These features included obesity, high blood pressure, prediabetic insulin resistance and cholesterol abnormalities. The team analysed more than 5,000 circulating proteins and isolated those whose levels were significantly tied to higher cardiometabolic risk. Six proteins emerged from this screening [1]. They are not named in the public communications, which limits independent checking for now.

## Validation in adults

The same protein signature was then sought in 685 adult patients at high risk of irreversible cardiovascular, kidney and metabolic damage, and it was found there [1]. The team also used the records of more than 28,000 adults from the UK Biobank cohort. People carrying these proteins had a higher risk of myocardial infarction, diabetes, obesity, kidney disease or another cardiometabolic condition [1].

The authors also compared their results with clinical trials of GLP-1 analogues, drugs used against type 2 diabetes and obesity. In treated adults, levels of most proteins in the signature decreased [1]. Senior author Kari North regards this as evidence of a modifiable risk factor and calls for better screening of at-risk children. First author Heather Highland said such markers could help identify people who need closer monitoring.

## Limits of the data

No child was followed into adulthood. The children were analysed at a single time point, the signature was compared with that of adults already at risk, and it was then validated in an adult cohort. The design therefore does not show that these children will develop the diseases [1].

The sample is modest: isolating six proteins out of more than 5,000 in 273 participants carries a risk of chance findings, which only independent replications can rule out. The fall in protein levels under GLP-1 treatment does not show that lowering them reduces disease risk, since these are intermediate markers. The treatment data concern adults only, and no such approach has been validated in children.

## Sources

1. [Futura Sciences](https://www.futura-sciences.com/sante/actualites/depistage-ce-revele-prise-sang-huit-ans-sante-decennies-plus-tard-k2m6-139036)

---

Source: RealTech, realtech.media — https://realtech.media/news/rt-a73799e634d1bb3bfc624834_vanderbilt_health_six/